Subcutaneous immunoglobulins replacement therapy in secondary antibody deficiencies: Real life evidence as compared to primary antibody deficiencies

Secondary antibody deficiencies (SAD) may require immunoglobulin replacement therapy (IgRT). While the intravenous route (IVIG) is broadly considered effective in SAD, the use of subcutaneous immunoglobulins (SCIG) is mainly adopted from the experience in primary antibody deficiencies (PAD), where S...

Descripción completa

Detalles Bibliográficos
Autores principales: Cinetto, Francesco, Neri, Raffaella, Vianello, Fabrizio, Visentin, Andrea, Barilà, Gregorio, Gianese, Sabrina, Lanciarotta, Alison, Milito, Cinzia, Rattazzi, Marcello, Piazza, Francesco, Trentin, Livio, Zambello, Renato, Agostini, Carlo, Scarpa, Riccardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7932095/
https://www.ncbi.nlm.nih.gov/pubmed/33661940
http://dx.doi.org/10.1371/journal.pone.0247717

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7932095/
https://www.ncbi.nlm.nih.gov/pubmed/33661940
http://dx.doi.org/10.1371/journal.pone.0247717

Ejemplares similares